Genomic & Biopharma News

Aircuity to install intelligent building platform at Virginia Commonwealth University
Aircuity, creator of measurably better environments, announces that it will begin installation at three laboratory research buildings at the Virginia Commonwealth University School of Medicine.
News Medical Life Sciences, 2017-12-12 13:08:00

Researchers identify promising solution for improving cystic fibrosis treatments
Researchers at the University of Montreal Hospital Research Centre have identified a promising solution to improving treatments offered to patients with cystic fibrosis.
News Medical Life Sciences, 2017-12-12 13:07:05

Granatum – the user-friendly web tool for single cell RNA sequencing analysis
Single-cell RNA sequencing (scRNA-seq) is a frontier research area that studies genomic events down to the individual cell level, providing unprecedented insights into many biological and medical questions, such as cancer heterogeneity and tumor...
Transcriptome Research & Industry News, 2017-12-12 13:02:31

Novel compound inhibits mycomembrane biosynthesis and kills tuberculosis bacteria
Tuberculosis is one of the most widespread life-threatening infectious diseases. Not only does antibiotic resistance make treatment increasingly difficult, but the bacteria’s relatively impermeable mycomembrane also limits the effectiveness of many drugs.
News Medical Life Sciences, 2017-12-12 12:57:00

Hidden genes hold blueprints for designing new anti-cancer drugs
New research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.
News Medical Life Sciences, 2017-12-12 12:55:32

Ex-Dezima executives scoop €25M for midphase NASH trial
NorthSea Therapeutics has raised €25 million ($29 million) to put a NASH drug through phase 2b. The round reunites some of the executives and investors who helped Dezima and NASH startup Akarna to takeovers by Amgen and Allergan, respectively.
Fierce Biotech, 2017-12-12 11:35:30

Medherant raises £3.8 million for transdermal patch
Coventry, UK-based Medherant has raised £3.8 million in its latest funding round to help further development of its ibuprofen TEPI Patch.
PharmaTimes, 2017-12-12 11:27:20

US clears Sanofi’s ‘follow-on’ insulin Admelog
The US Food and Drug Administration has cleared Sanofi's Admelog, the first follow-on biologic version of Eli Lilly’s Humalog, to manage mealtime blood sugar levels in people with diabetes.
PharmaTimes, 2017-12-12 11:14:35

Scotland approves NHS funding for Ibrance, Cerdelga and Invicorp
The latest batch of decisions by the Scottish Medicines Consortium has given patients with certain forms of breast cancer, Gaucher disease and erectile dysfunction new treatment options on the NHS.
PharmaTimes, 2017-12-12 10:43:37